Dr. Zachary B. Bulwa, MD, MS

Dr. Bulwa practices at Northshore University Healthsystem Faculty Practice Associates in Skokie, Illinois.

Dr. Bulwa's NPI, 1164876553, was assigned on April 21, 2016. Dr. Bulwa holds Illinois license 036152509.

Dr. Bulwa's primary practice is Northshore University Healthsystem Faculty Practice Associates, at 9650 Gross Point Rd, Skokie, IL 60076 in Cook County. The practice phone is (847) 570-5235.

Dr. Bulwa's primary practice is Northshore University Healthsystem Faculty Practice Associates in Skokie, Illinois. Dr. Bulwa is also affiliated with Evanston Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Bulwa to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bulwa practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bulwa's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bulwa is licensed in Illinois.

CMS data shows 1,153 Medicare services from Dr. Bulwa across 9 procedure codes in 2024, for 511 Medicare patients. Medicare paid $107,939 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 511 Medicare patients who saw Dr. Bulwa in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bulwa's median patient age at 76, with 52% women.

In 2024, Dr. Bulwa wrote 1,365 Medicare Part D claims for 297 patients. 85% of them were for generic drugs. CMS names the drug for 1,097 of them, across 22 drugs with 11 or more claims each, at $146,527 in total drug cost. In 2023, CMS named 599 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Bulwa for performance year 2024, reported as part of a group. Dr. Bulwa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bulwa as offering telehealth.

Dmand AI links 31 papers to Dr. Bulwa, published from 2011 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Stroke, Brain Ischemia and Cerebral Hemorrhage. Dr. Bulwa has published most often in J Stroke Cerebrovasc Dis. Dr. Bulwa's most frequent co-authors are James R. Brorson, Fernando D. Goldenberg and Andrea Loggini, MD.

Dmand AI links Dr. Bulwa to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ischemic Stroke and Ischemia.

CMS Open Payments shows 4 general payments to Dr. Bulwa from 4 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $111.